Tags |
|
|
Links |
|
|
Answers - Living Trust Investing: Income Considerations when the Grantor Dies
A common problem I often see when working with living trust beneficiaries and trustees is the lack of attention in rethinking income strategies in the event of the grantor's death.
When the grantor of a
When the grantor of a
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
living trust dies, the trustee (especially a family member or close friend) sometimes feels reluctant to revise the portfolio, feeling it's an affront to the wishes of the deceased. After all, if the inve
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
tments were sound during life, they should be sound enough upon his or her death.
While the fundamental values of the investments are certainly the same, a number of circumstances have changed and must b
While the fundamental values of the investments are certainly the same, a number of circumstances have changed and must b
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
dealt with.
The most crucial change is because of the trust itself. There are sections within the trust instrument that deal with income distributions, both during the grantor's lifetime and after his o
The most crucial change is because of the trust itself. There are sections within the trust instrument that deal with income distributions, both during the grantor's lifetime and after his o
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
her death. The trustee should become familiar with these sections and how their differences will have an impact upon investment decisions.
Secondly, with the passing of the grantor, new assets (such as
Secondly, with the passing of the grantor, new assets (such as
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ife insurance death benefits) are often added to the trust assets and these new assets must be invested in a way that complies with the grantor's wishes.
Thirdly, assets held outside the trust often need
Thirdly, assets held outside the trust often need
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
to be considered. For example, the grantor may have held qualified retirement plan benefits that are passed directly to a trust
beneficiary. Utilization of these retirement benefits may need to be recog
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ized and, in some instances, may even be discussed in the trust instrument.
Lastly, the trust beneficiaries may have assets of their own and these asets should be brought into the mix of things.
When re
Lastly, the trust beneficiaries may have assets of their own and these asets should be brought into the mix of things.
When re
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ising an investment strategy, the needs of the income beneficiaries are a good place to start. First, determine available cash flow from sources outside the trust. Typically, this could include Social Sec
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
rity benefits, immediate annuities, deferred compensation, qualified retirement plans and, of course, the beneficary's own assets.
Next, fund whatever income deficit is left by assuming a modest rate of
Next, fund whatever income deficit is left by assuming a modest rate of
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ield in the trust. Hopefully, this modest amount will satisfy the needs of the income beneficiaries. If not, you can raise the yield somewhat, but not too much. At some point, you'll reach beyond what yie
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ld can be readily achieved with an acceptable risk level, to speak nothing of breaching the trustee's responsibility to act in a prudent fashion.
Because the trustee has a responsibility to all beneficia
Because the trustee has a responsibility to all beneficia
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ies, including those who may ultimately inherit the trust, it may be necessary to balance the income needs of the income beneficiaries and the growth needs of the ultimate beneficiaries. This fidicuary ro
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
e is paramount to the decisions made by the trustee.
It is also important to note the difference between "yield" and "total return," as applied to a trust. Total return includes capital gains, but those
It is also important to note the difference between "yield" and "total return," as applied to a trust. Total return includes capital gains, but those
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ains are often excluded from the definition of "distributable income" in a trust. Distributions that exceed income will be construed as principal and are often left to a trustee's discretion. A trustee ca
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
say "no" as easily as "yes" to principal distributions.
If principal distributions are left to the trustee's discretion, it's a good guess that the intent was not to punish the beneficiary, but to keep
If principal distributions are left to the trustee's discretion, it's a good guess that the intent was not to punish the beneficiary, but to keep
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
the trust out of the beneficiary's taxable estate.
Carrying this one step farther, many financial advisers will argue that, if a beneficiary's own estate is large enough to be exposed to estate taxes, th
Carrying this one step farther, many financial advisers will argue that, if a beneficiary's own estate is large enough to be exposed to estate taxes, th
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
n the beneficiary might be wise to "spend down" his or her own estate and let the trust grow in value.
The inverse is also true. If a beneficiary has a small estate, then he or she may want income from t
The inverse is also true. If a beneficiary has a small estate, then he or she may want income from t
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
e trust, but he or she may also want the principal to grow in his or her own name so as to get a stepped-up tax basis upon death.
These strategies are very common if the ultimate beneficiaries are the sa
These strategies are very common if the ultimate beneficiaries are the sa
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
e people.
The role of the trustee can be difficult, but paying attention to the changes in income needs will avoid future problems and inefficiencies in carrying out the duties of administering the trust
The role of the trustee can be difficult, but paying attention to the changes in income needs will avoid future problems and inefficiencies in carrying out the duties of administering the trust
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/117869/answers-Living-Trust-Investing-Income-Considerations-when-the-Grantor-Dies.html">Living Trust Investing: Income Considerations when the Grantor Dies</a>
BB link (for phorums):
[url=http://www.answers.org.ua/article/117869/answers-Living-Trust-Investing-Income-Considerations-when-the-Grantor-Dies.html]Living Trust Investing: Income Considerations when the Grantor Dies[/url]
Related Articles:
Top-Ten Reasons Why People Quit Their Jobs
How To Quickly Build An Opt In Email List For Your Affiliate Program
Personal Loans for the Traveller in You
Bookmark it:
|